chr3-121854688-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_018456.6(EAF2):c.203G>T(p.Gly68Val) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000721 in 1,386,182 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018456.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EAF2 | NM_018456.6 | c.203G>T | p.Gly68Val | missense_variant, splice_region_variant | 3/6 | ENST00000273668.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EAF2 | ENST00000273668.7 | c.203G>T | p.Gly68Val | missense_variant, splice_region_variant | 3/6 | 1 | NM_018456.6 | P1 | |
EAF2 | ENST00000490434.5 | c.202-2323G>T | intron_variant, NMD_transcript_variant | 1 | |||||
EAF2 | ENST00000451944.2 | c.203G>T | p.Gly68Val | missense_variant, splice_region_variant | 3/6 | 2 | |||
EAF2 | ENST00000490477.1 | c.*245G>T | splice_region_variant, 3_prime_UTR_variant, NMD_transcript_variant | 4/5 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 7.21e-7 AC: 1AN: 1386182Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 688848
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 22, 2024 | The c.203G>T (p.G68V) alteration is located in exon 3 (coding exon 3) of the EAF2 gene. This alteration results from a G to T substitution at nucleotide position 203, causing the glycine (G) at amino acid position 68 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.